These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 4116458

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of bleomycin on human and experimental squamous carcinoma.
    Michaels L, Grey PA, Rowson KE.
    J Pathol; 1973 Apr; 109(4):315-21. PubMed ID: 4124412
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical and pathological observations on malignant tumors of the head and neck region treated with bleomycin].
    Nakamura S, Murakami Y, Hashiguchi T, Kuga G, Yanagi Y.
    Jibiinkoka; 1969 Jul; 41(7):465-77. PubMed ID: 5817277
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Chemotherapy by intra-arterial path in cancer of the "head and neck" region].
    Mayer M, Colon J.
    Acta Chir Belg; 1971 Apr; 70(4):337-50. PubMed ID: 4111136
    [No Abstract] [Full Text] [Related]

  • 7. Methotrexate therapy for squamous cell carcinomas of the head and neck. Intermittent intravenous dose program.
    Lane M, Moore JE, Levin H, Smith FE.
    JAMA; 1968 May 13; 204(7):561-4. PubMed ID: 5694477
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Methotrexate therapy of head and neck cancer: improvement in therapeutic index by the use of leucovorin "rescue".
    Capizzi RL, DeConti RC, Marsh JC, Bertino JR.
    Cancer Res; 1970 Jun 13; 30(6):1782-8. PubMed ID: 4248129
    [No Abstract] [Full Text] [Related]

  • 11. Effectiveness of high-dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck.
    Mitchell MS, Wawro NW, DeConti RC, Kaplan SR, Papac R, Bertino JR.
    Cancer Res; 1968 Jun 13; 28(6):1088-94. PubMed ID: 4298056
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of oral and maxillofacial squamous cell carcinomas by zhenguangmycin---with discussion on the similarities and differences between zhenguangmycin and bleomycin (author's transl)].
    Zhonghua Kou Qiang Ke Za Zhi; 1979 Jun 13; 14(2):77-9. PubMed ID: 95503
    [No Abstract] [Full Text] [Related]

  • 13. Clinical and pharmacologic effects of combinations of 6-thioguanine and duazomycin A in patients with neoplastic disease.
    Lefkowitz ER, Creasey WA, Calabresi P, Sartorelli AC.
    Cancer Res; 1965 Sep 13; 25(8):1207-12. PubMed ID: 5839715
    [No Abstract] [Full Text] [Related]

  • 14. Bleomycin in malignant tumors of head and neck.
    Suzuki Y, Miyake H, Sakai M, Inuyama Y, Matsukawa J.
    Keio J Med; 1969 Sep 13; 18(3):153-62. PubMed ID: 5365968
    [No Abstract] [Full Text] [Related]

  • 15. The treatment of squamous cell carcinoma of the head and neck with methotrexate and irradiation.
    Friedman M, Daly JF.
    Am J Roentgenol Radium Ther Nucl Med; 1967 Feb 13; 99(2):289-301. PubMed ID: 6020797
    [No Abstract] [Full Text] [Related]

  • 16. Kinetically-based multiple drug treatment for advanced head and neck cancer.
    Price LA, Hill BT, Calvert AH, Shaw HJ, Hughes KB.
    Br Med J; 1975 Jul 05; 3(5974):10-1. PubMed ID: 48403
    [Abstract] [Full Text] [Related]

  • 17. Synchronized combination bleomycin-methotrexat in regional chemotherapy of orofacial carcinomas.
    Bilder J, Hornová J.
    Neoplasma; 1974 Jul 05; 21(3):335-42. PubMed ID: 4138497
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Use of bleomycin in patients with incurable carcinoma of the oral cavity].
    Fries R, Wilfert KH.
    Osterr Z Erforsch Bekampf Krebskr; 1973 Jul 05; 28(1):29-32. PubMed ID: 4123658
    [No Abstract] [Full Text] [Related]

  • 20. [Experiences with intratumor application of bleomycin-oil suspension (BOS) in cancers of the mouth, oropharynx and maxillary sinus].
    Mika H.
    HNO; 1982 Dec 05; 30(12):457-61. PubMed ID: 6186651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.